ATF3 and prostate cancer: ATF3 expression was related to glycosaminoglycan degradation, pathways in cancer, prostate cancer, and TGF-β signaling (Figure 7B), and DUSP1 was associated with adipocytokine signaling, graft vs. host disease, pathways in cancer, and small cell lung cancer (Figure 7C).